131 related articles for article (PubMed ID: 33378013)
1. Long-chain non-coding RNA LINC01554 promotes NGFR expression and inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma by binding to microRNA-3681-3p.
Hao QY; Gao LH; Niu WY; Wang GJ; Zhang P; Chen L; Zhu DM; Shao WB
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12667-12674. PubMed ID: 33378013
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1.
Wei YY; Ren TL
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12144-12152. PubMed ID: 33336732
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-363-3p/RNF38 axis.
Hu PA; Miao YY; Yu S; Guo N
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3592-3604. PubMed ID: 32329834
[TBL] [Abstract][Full Text] [Related]
5. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
[No Abstract] [Full Text] [Related]
6. LINC01296 promotes the proliferation and invasion by regulating microRNA-760 expression and predicts poor prognosis of hepatocellular carcinoma.
Wang ZC; Yang S; Chen MQ; Wu SS; Lv HH; Jin WX
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9848-9856. PubMed ID: 31799652
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma.
Li L; Huang K; Lu Z; Zhao H; Li H; Ye Q; Peng G
Oncol Rep; 2020 Nov; 44(5):2185-2197. PubMed ID: 33000250
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00858 promotes cells proliferation and invasion through the miR-153-3p/Rabl3 axis in hepatocellular carcinoma.
Qi WY; Mao XB; He YB; Xiao CH
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9343-9352. PubMed ID: 33015775
[TBL] [Abstract][Full Text] [Related]
9. ATG4 promotes cell proliferation, migration and invasion in HCC and predicts a poor prognosis.
Zhu XJ; Jin X; Dai L; Liu X; Liu Z
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12686-12693. PubMed ID: 33378015
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
Li H; Yuan R; Wang H; Li C; Wei J
J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level.
Li JZ; Li J; Liu BZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9331-9340. PubMed ID: 31773692
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circSOX4 promotes the proliferation, migration and apoptosis of hepatocellular carcinoma cells by down regulating microRNA-432 expression.
Wen Z; Guo YX; Sun HD
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1845-1852. PubMed ID: 33660794
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis.
Zhang L; Hu J; Hao M; Bu L
Biol Chem; 2020 Feb; 401(3):407-416. PubMed ID: 31318685
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ZFAS1 promotes hepatocellular carcinoma proliferation by epigenetically repressing miR-193a-3p.
Zhou HL; Zhou YF; Feng ZT
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9840-9847. PubMed ID: 31799651
[TBL] [Abstract][Full Text] [Related]
16. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
[TBL] [Abstract][Full Text] [Related]
17. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
Yin J; Liu Q; Chen C; Liu W
J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA RP11-909N17.2 promotes proliferation, invasion, and migration of hepatocellular carcinoma by regulating microRNA-767-3p.
Liu Q; Dai SJ; Dong L; Li H
Biochem Cell Biol; 2020 Dec; 98(6):709-718. PubMed ID: 33210543
[TBL] [Abstract][Full Text] [Related]
19. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.
Bu WJ; Fang Z; Li WL; Wang X; Dong MJ; Tao QY; Zhang L; Xu YQ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10452-10461. PubMed ID: 33155201
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
